Literature DB >> 3683172

Detection of malignant tumors: water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.

T L Dowd1, B A Kaplan, R K Gupta, P Aisen.   

Abstract

Average linewidths of methyl and methylene proton resonances of plasma lipoproteins from healthy controls and untreated cancer patients were measured in water-suppressed proton spectra obtained at 400 MHz. In contrast to a previous report (E. T. Fossel, J. M. Carr, and J. McDonagh, N. Engl. J. Med. 315, 1369 (1986] no statistically significant difference (P greater than 0.5) was found between the average linewidths in plasma samples from 20 normal controls (36.0 +/- 6.4 Hz) and 17 untreated cancer patients (34.6 +/- 6.3 Hz). When the effect of lactate was removed by graphical extrapolation, a small but marginally significant (P = 0.08) difference was observed between the average linewidths of the normal controls (35.1 +/- 5.8 Hz) and untreated cancer patients (31.8 +/- 5.2 Hz). However, there was still a large overlap between the two groups. In addition, substantial day to day variations in the linewidths of samples from the same individuals were observed. We conclude that these measurements cannot be used to detect cancer.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3683172     DOI: 10.1002/mrm.1910050414

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  2 in total

1.  Nuclear magnetic resonance spectroscopy of plasma to distinguish between malignant and benign diseases causing jaundice and cholestasis.

Authors:  P A Pasanen; R Kauppinen; M J Eskelinen; K P Partanen; P H Pikkarainen; E M Alhava
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

2.  Some factors that influence the plasma lipoprotein 1H NMR spectra of normal and cancer patients: an oncolipid test?

Authors:  H M Lim; T B Price; J C Marsh; P M Rainey; J C Gore; I M Armitage
Journal:  Yale J Biol Med       Date:  1991 Jan-Feb
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.